Inhibition of NF-kappaB activation by Pyrrolidine dithiocarbamate partially attenuates hippocampal MMP-9 activation and improves cognitive deficits in streptozotocin-induced diabetic rats

Behavioural Brain Research

Volumn 238, Issue 1, 2013, Pages 44-47

  Zhao, Zhe ^a   Huang, Gaozhong ^a   Wang, Beiyun ^a   Zhong, Yuan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

Cognitive impairment; Diabetes; MMP 9; NF B

Indexed keywords

GELATINASE B; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PYRROLIDINE DITHIOCARBAMATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; BEHAVIOR DISORDER; BODY WEIGHT; BRAIN LEVEL; COGNITIVE DEFECT; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; GLUCOSE BLOOD LEVEL; HIPPOCAMPUS; INHIBITION KINETICS; LATENT PERIOD; MALE; MAZE TEST; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES; UPREGULATION;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; GENE EXPRESSION REGULATION; HIPPOCAMPUS; MALE; MATRIX METALLOPROTEINASE 9; MAZE LEARNING; NF-KAPPA B; PROMOTER REGIONS, GENETIC; PYRROLIDINES; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; THIOCARBAMATES;

EID: 84868543286     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.10.018     Document Type: Article

References (25)

1. Kuhad A., Sethi R., Chopra K. Lycopene attenuates diabetes-associated cognitive decline in rats. Life Sciences 2008, 83:128-134.
2. Kuhad A., Bishnoi M., Tiwari V., Chopra K. Suppression of NF-kappabeta signaling pathway by tocotrienol can prevent diabetes associated cognitive deficits. Pharmacology Biochemistry and Behavior 2009, 92:251-259.
3. Maiese K., Chong Z.Z., Shang Y.C. Mechanistic insights into diabetes mellitus and oxidative stress. Current Medicinal Chemistry 2007, 14:1729-1738.
4. Sims-Robinson C., Kim B., Rosko A., Feldman E.L. How does diabetes accelerate Alzheimer disease pathology. Nature Reviews Neurology 2010, 6:551-559.
5. de la Monte S.M., Tong M., Lester-Coll N., Plater M., Wands J.R. Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer's disease. Journal of Alzheimer's Disease 2006, 10:89-109.
6. Kumar A., Negi G., Sharma S.S. Suppression of NF-κB and NF-κB regulated oxidative stress and neuroinflammation by BAY 11-7082 (IκB phosphorylation inhibitor) in experimental diabetic neuropathy. Biochimie 2012, 94:1158-1165.
7. Wu K.I., Schmid-Schonbein G.W. Nuclear factor kappa B and matrix metalloproteinase induced receptor cleavage in the spontaneously hypertensive rat. Hypertension 2011, 57:261-268.
8. McColl B.W., Rothwell N.J., Allan S.M. Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice. Journal of Neuroscience 2008, 28:9451-9462.
9. Hawkins B.T., Lundeen T.F., Norwood K.M., Brooks H.L., Egleton R.D. Increased blood-brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases. Diabetologia 2007, 50:202-211.
10. Gaudet J.G., Yocum G.T., Lee S.S., Granat A., Mikami M., Connolly E.S., et al. MMP-9 levels in elderly patients with cognitive dysfunction after carotid surgery. Journal of Clinical Neuroscience 2010, 17:436-440.
11. Mizoguchi H., Takuma K., Fukuzaki E., Ibi D., Someya E., Akazawa K.H., et al. Matrix metalloprotease-9 inhibition improves amyloid beta-mediated cognitive impairment and neurotoxicity in mice. Journal of Pharmacology and Experimental Therapeutics 2009, 331:14-22.
12. Hayden M.S., Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008, 132:344-362.
13. Wang Z., Leng Y., Tsai L.K., Leeds P., Chuang D.M. Valproic acid attenuates blood-brain barrier disruption in a rat model of transient focal cerebral ischemia: the roles of HDAC and MMP-9 inhibition. Journal of Cerebral Blood Flow and Metabolism 2011, 31:52-57.
14. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. Journal of Neuroscience Methods 1984, 11:47-60.
15. Kamal A., Biessels G.J., Duis S.E., Gispen W.H. Learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: interaction of diabetes and ageing. Diabetologia 2000, 43:500-506.
16. Baydas G., Nedzvetskii V.S., Nerush P.A., Kirichenko S.V., Yoldas T. Altered expression of NCAM in hippocampus and cortex may underlie memory and learning deficits in rats with streptozotocin-induced diabetes mellitus. Life Sciences 2003, 73:1907-1916.
17. Artola A. Diabetes-, stress- and ageing-related changes in synaptic plasticity in hippocampus and neocortex - the same metaplastic process. European Journal of Pharmacology 2008, 585:153-162.
18. Mohammad G., Kowluru R.A. Diabetic retinopathy and signaling mechanism for activation of matrix metalloproteinase-9. Journal of Cellular Physiology 2012, 227:1052-1061.
19. Nagy V., Bozdagi O., Huntley G.W. The extracellular protease matrix metalloproteinase-9 is activated by inhibitory avoidance learning and required for long-term memory. Learning and Memory 2007, 14:655-664.
20. Wang X.B., Bozdagi O., Nikitczuk J.S., Zhai Z.W., Zhou Q., Huntley G.W. Extracellular proteolysis by matrix metalloproteinase-9 drives dendritic spine enlargement and long-term potentiation coordinately. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:19520-19525.
21. Mizoguchi H., Yamada K., Nabeshima T. Matrix metalloproteinases contribute to neuronal dysfunction in animal models of drug dependence, Alzheimer's disease, and epilepsy. Biochemistry Research International 2011, 2011:681385.
22. Jourquin J., Tremblay E., Decanis N., Charton G., Hanessian S., Chollet A.M., et al. Neuronal activity-dependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainate. European Journal of Neuroscience 2003, 18:1507-1517.
23. Yang Y., Estrada E.Y., Thompson J.F., Liu W., Rosenberg G.A. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. Journal of Cerebral Blood Flow and Metabolism 2007, 27:697-709.
24. Liu S.F., Ye X., Malik A.B. In vivo inhibition of nuclear factor-kappa B activation prevents inducible nitric oxide synthase expression and systemic hypotension in a rat model of septic shock. Journal of Immunology 1997, 159:3976-3983.
25. Li J., Sheng W., Feng C., Zuo Z. Pyrrolidine dithiocarbamate attenuates brain Abeta increase and improves long-term neurological outcome in rats after transient focal brain ischemia. Neurobiology of Disease 2012, 45:564-572.